Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 21, 6 (2021).

Article  Google Scholar 

Kelley, R. K. et al. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 23, 995–1008 (2022).

Article  CAS  PubMed  Google Scholar 

Sangro, B. et al. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. Ann. Oncol. 35, 448–457 (2024).

Article  CAS  PubMed  Google Scholar 

Ding, Z. W. et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat. Commun. 14, 6269 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, M. et al. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu–Fe balance in hepatocellular carcinoma. J. Hepatol. 76, 1138–1150 (2022).

Article  CAS  PubMed  Google Scholar 

Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hadian, K. & Stockwell, B. R. SnapShot: ferroptosis. Cell 181, 1188 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599–620 (2021).

Article  CAS  PubMed  Google Scholar 

Wang, Z. J. et al. The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma. Cell Death Dis. 14, 695 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu, Z. M. et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc. Natl Acad. Sci. USA 116, 2996–3005 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Way, G., Morrice, N., Smythe, C. & O’Sullivan, A. J. Purification and identification of secernin, a novel cytosolic protein that regulates exocytosis in mast cells. Mol. Biol. Cell 13, 3344–3354 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindhout, F. W. et al. VAP–SCRN1 interaction regulates dynamic endoplasmic reticulum remodeling and presynaptic function. EMBO J. 38, e101345 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pires, G. et al. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies. Acta. Neuropathol. Commun. 7, 195 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin, S.T. et al. Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis. Dis. Markers 2015, 230703 (2015).

Du, Z., Tong, X. & Ye, X. Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4. J. Biol. Chem. 288, 26678–26687 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fukasawa, T., Enomoto, A. & Miyagawa, K. Serine-threonine kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint. Cell Signal. 27, 1569–1575 (2015).

Article  CAS  PubMed  Google Scholar 

Liu, Z. et al. Downregulated NDR1 protein kinase inhibits innate immune response by initiating an miR146a–STAT1 feedback loop. Nat. Commun. 9, 2789 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Martin, A. P., Aushev, V. N., Zalcman, G. & Camonis, J. H. The STK38–XPO1 axis, a new actor in physiology and cancer. Cell. Mol. Life Sci. 78, 1943–1955 (2021).

Article  CAS  PubMed  Google Scholar 

Li, Y. R. et al. LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma. Cell Death Dis. 11, 685 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Beaufrère, A. et al. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J. Hepatol. 76, 343–352 (2022).

Article  PubMed  Google Scholar 

Wei, X. B. et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study. J. Clin. Oncol. 37, 2141–2151 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamaya, S. et al. Cisplatin in liver cancer therapy. Int. J. Mol. Sci. 24, 13 (2023).

Article  Google Scholar 

Kim, D. H. et al. Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes. Redox Biol. 54, 102382 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu, S. et al. GPX4 degradation via chaperone-mediated autophagy contributes to antimony-triggered neuronal ferroptosis. Ecotoxicol. Environ. Saf. 234, 113413 (2022).

Article  CAS  PubMed  Google Scholar 

Cui, C., Yang, F. & Li, Q. Post-translational modification of GPX4 is a promising target for treating ferroptosis-related diseases. Front. Mol. Biosci. 9, 901565 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, L. M., Klionsky, D. J. & Shen, H. M. The emerging mechanisms and functions of microautophagy. Nat. Rev. Mol. Cell Biol. 24, 186–203 (2023).

Article  CAS  PubMed  Google Scholar 

Qiao, L. et al. LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. Autophagy 19, 2837–2852 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue, Q. et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy 19, 1982–1996 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kiffin, R., Christian, C., Knecht, E. & Cuervo, A. M. Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell 15, 4829–4840 (2004).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaushik, S. & Cuervo, A. M. The coming of age of chaperone-mediated autophagy. Nat. Rev. Mol. Cell Biol. 19, 365–381 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen, M. Y. et al. STK38 protein kinase preferentially inhibits TLR9-activated inflammatory responses by promoting MEKK2 ubiquitination in macrophages. Nat. Commun. 6, 7167 (2015).

Article  CAS  PubMed